Talis Biomedical Corporation (TLIS)

Talis Biomedical Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Assets

Fiscal Year	TTM	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Jun 30, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Cash & Equivalents	59.87	76.73	130.19	232.55	138.48	21.6
Cash & Short-Term Investments	59.87	76.73	130.19	232.55	138.48	21.6
Cash Growth	-39.04%	-41.06%	-44.02%	67.92%	541.01%	213.33%
Receivables	-	0.05	0.31	0.18	0.47	1.81
Prepaid Expenses	3.73	0.9	2.78	3.39	0.71	0.43
Restricted Cash	-	-	-	-	34.65	-
Other Current Assets	-	-	-	-	14.41	0.27
Total Current Assets	63.6	77.68	133.28	236.12	188.72	24.11
Property, Plant & Equipment	8.33	15.45	34.23	23.44	9.68	1.54
Other Long-Term Assets	0.77	1.54	1.78	6.28	-	0.09
Total Assets	72.7	94.67	169.29	265.83	198.41	25.73

Liabilities

Fiscal Year	TTM	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Jun 30, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Accounts Payable	3.79	1.34	3.77	5.12	4.91	1.57
Accrued Expenses	1.48	4.55	5.2	12.75	10.43	2.13
Current Portion of Leases	2.92	2.88	3.7	1.23	0.69	-
Other Current Liabilities	-	-	-	-	-	0.34
Total Current Liabilities	8.2	8.77	12.67	19.11	16.03	4.04
Long-Term Leases	15.88	16.79	29.88	12.75	-	-
Other Long-Term Liabilities	-	-	-	-	-	0.08
Total Liabilities	24.07	25.56	42.55	31.85	16.03	4.12

Shareholders' Equity

Fiscal Year	TTM	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Jun 30, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Common Stock	-	-	-	0	-	-
Additional Paid-In Capital	610.47	609.07	604.69	598.91	64.34	60.64
Retained Earnings	-561.85	-539.96	-477.95	-364.94	-172.91	-81.78
Total Common Equity	48.62	69.11	126.74	233.97	-108.57	-21.14
Shareholders' Equity	48.63	69.12	126.74	233.98	182.37	21.62
Total Liabilities & Equity	72.7	94.67	169.29	265.83	198.41	25.73

Additional Metrics

Fiscal Year	TTM	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Jun 30, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Total Debt	18.8	19.67	33.58	13.98	0.69	-
Net Cash (Debt)	41.07	57.06	96.61	218.57	137.79	21.6
Net Cash Growth	-47.23%	-40.93%	-55.80%	58.62%	537.80%	213.33%
Net Cash Per Share	22.55	31.40	53.66	144.71	974.78	150.68
Filing Date Shares Outstanding	1.82	1.82	1.79	1.78	1.71	0.14
Total Common Shares Outstanding	1.82	1.82	1.79	1.76	0.14	0.14
Working Capital	55.41	68.91	120.61	217.01	172.69	20.07
Book Value Per Share	26.68	37.93	70.95	132.90	-765.93	-149.89
Tangible Book Value	48.62	69.11	126.74	233.97	-108.57	-21.14
Tangible Book Value Per Share	26.68	37.93	70.95	132.90	-765.93	-149.89
Machinery	-	14.72	13.9	8.99	4.72	2.96
Construction In Progress	-	-	0.98	4.72	6.58	-
Leasehold Improvements	-	1.25	1.25	0.81	0.81	0.81

Data Source: S&P Global Market Intelligence Last updated: Jun 30, 2024

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Dec 18, 2025

Data Sources Report a data error